Skip to main content
. 2021 Mar 30;15(10):1694–1706. doi: 10.1093/ecco-jcc/jjab058

Figure 5.

Figure 5.

Adjusted cumulative rates of treatment persistence in ulcerative colitis and Crohn’s disease patients.*The sum of the patient weights for each group still on treatment and at clinical outcome can still be assessed.